U.S. Markets closed

Accelerate Diagnostics, Inc. (AXDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.26-0.22 (-4.01%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.48
Bid5.11 x 1000
Ask5.81 x 1300
Day's Range5.14 - 5.55
52 Week Range5.01 - 15.60
Avg. Volume341,887
Market Cap321.091M
Beta (5Y Monthly)1.88
PE Ratio (TTM)N/A
EPS (TTM)-1.42
Earnings DateAug 04, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
  • PR Newswire

    New Accelerate Pheno® System Multi-Center Study Published in Clinical Infectious Diseases

    Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the publication of its Improving Outcomes and Antibiotic Stewardship (IOAS) Study in the journal Clinical Infectious Diseases. The multi-center, real-world study compared data before and after implementation of the Accelerate Pheno system across several hospitals to determine its impact on the treatment of patients with bloodstream infections. The data showed statistically significant reductions in time to optimal antimicrobial therapy,

  • Zacks

    Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

    Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 57.14% and -11.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire

    Accelerate Diagnostics Reports Third Quarter 2021 Financial Results

    Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the third quarter for the period ended September 30, 2021, which remain subject to quarter end closing adjustments.